AC Immune SA annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AC Immune SA Capital Expenditures (CapEx) Growth & History (ACIU)
AC Immune SA's capital expenditures (capex) was CHF900,000 for fiscal 2025.
View full AC Immune SA company overviewAC Immune SA annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF900,000 | CHF324,000 | +56.25% |
| 2024 | 2024-12-31 | CHF576,000 | −CHF225,000 | −28.09% |
| 2023 | 2023-12-31 | CHF801,000 | −CHF438,000 | −35.35% |
| 2022 | 2022-12-31 | CHF1.2M | −CHF1.4M | −52.98% |
| 2021 | 2021-12-31 | CHF2.6M | CHF929,000 | +54.45% |
| 2020 | 2020-12-31 | CHF1.7M | −CHF179,000 | −9.50% |
| 2019 | 2019-12-31 | CHF1.9M | CHF27,000 | +1.45% |
| 2018 | 2018-12-31 | CHF1.9M | CHF56,000 | +3.11% |
| 2017 | 2017-12-31 | CHF1.8M | CHF903,000 | +100.44% |
| 2016 | 2016-12-31 | CHF899,000 | CHF655,000 | +268.44% |
| 2015 | 2015-12-31 | CHF244,000 | — | — |
AC Immune SA quarterly capital expenditures (capex)
Q3.22
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | CHF107,000 | CHF17,000 | +18.89% |
| Q3 2025 | 2025-09-30 | CHF58,000 | — | — |
| Q2 2025 | 2025-06-30 | CHF373,000 | — | — |
| Q1 2025 | 2025-03-31 | CHF362,000 | — | — |
| Q4 2024 | 2024-12-31 | CHF90,000 | — | — |
| Q3 2022 | 2022-09-30 | CHF121,000 | — | — |
AC Immune SA capital expenditures (capex) trends
Over the last five fiscal years, AC Immune SA's capital expenditures (capex) decreased from CHF1.7M to CHF900,000, a change of −CHF806,000. The latest reported quarter, Q4 2025, shows CHF107,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AC Immune SA source filings ↗